Literature DB >> 19373238

Effect of chronic kidney disease on individual and population medical expenditures in the Japanese population.

Aya Higashiyama1, Tomonori Okamura, Makoto Watanabe, Yoshitaka Murakami, Hidemi Otsuki, Noriko Adachi, Chiaki Kaneko, Emi Uehara, Akira Okayama, Hirotsugu Ueshima.   

Abstract

Chronic kidney disease (CKD) is associated with increased risk of cardiovascular disease (CVD), and may also lead to an increase in medical expenditures. The effect of CKD on individual and population medical expenditures was examined in a Japanese cohort study. The participants included 4026 Japanese National Health Insurance beneficiaries aged 40-74 years living in one city, who had no history of major CVD. They were classified into three categories according to their glomerular filtration rate (GFR) at the baseline survey, and their total medical expenditures were followed-up for 3 years. The arithmetic and geometric means of the cumulative medical expenditures were calculated for each category. The geometric mean was also expressed after adjusting for several confounding factors using analysis of covariance. The CKD-related medical expenditures attributable to the participants with mild (60 < or = GFR < 90) or moderate (30 < or = GFR < 60) kidney dysfunction were compared with those of participants with normal (GFR > or = 90) kidney function. There was a negative correlation between the GFR category and the arithmetic and geometric means of personal medical expenditures (adjusted geometric mean: GFR > or = 90, 167,879 yen; 60 < or = GFR < 90, 210,660 yen; and 30 < or = GFR < 60, 330,050 yen). The CKD-related medical expenditures accounted for 11.5 and 6.5% of the total medical expenditures for the participants with mild and moderate kidney dysfunction, respectively. The prevention of mild CKD is very important for containing medical expenditures. Appropriate strategies, such as regular creatinine measurement, are needed for early detection of CKD.

Entities:  

Mesh:

Year:  2009        PMID: 19373238     DOI: 10.1038/hr.2009.51

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  13 in total

1.  Plasma aldosterone and its relationship with left ventricular mass in hypertensive patients with early-stage chronic kidney disease.

Authors:  Giuseppe Mulè; Emilio Nardi; Laura Guarino; Valentina Cacciatore; Giulio Geraci; Ilenia Calcaterra; Bruno Oddo; Francesco Vaccaro; Santina Cottone
Journal:  Hypertens Res       Date:  2015-01-08       Impact factor: 3.872

2.  Cost-Effectiveness Analysis of Initiating Type 2 Diabetes Therapy with a Sodium-Glucose Cotransporter 2 Inhibitor Versus Conventional Therapy in Japan.

Authors:  Ataru Igarashi; Keiko Maruyama-Sakurai; Anna Kubota; Hiroki Akiyama; Toshitaka Yajima; Shun Kohsaka; Hiroaki Miyata
Journal:  Diabetes Ther       Date:  2022-06-16       Impact factor: 3.595

Review 3.  The global impact of non-communicable diseases on households and impoverishment: a systematic review.

Authors:  Loes Jaspers; Veronica Colpani; Layal Chaker; Sven J van der Lee; Taulant Muka; David Imo; Shanthi Mendis; Rajiv Chowdhury; Wichor M Bramer; Abby Falla; Raha Pazoki; Oscar H Franco
Journal:  Eur J Epidemiol       Date:  2014-12-21       Impact factor: 8.082

4.  Impact of CKD on Household Income.

Authors:  Rachael L Morton; Iryna Schlackow; Alastair Gray; Jonathan Emberson; William Herrington; Natalie Staplin; Christina Reith; Kirsten Howard; Martin J Landray; Alan Cass; Colin Baigent; Borislava Mihaylova
Journal:  Kidney Int Rep       Date:  2017-12-23

5.  Higher medical costs for CKD patients with a rapid decline in eGFR: A cohort study from the Japanese general population.

Authors:  Kei Nagai; Chiho Iseki; Kunitoshi Iseki; Masahide Kondo; Koichi Asahi; Chie Saito; Ryoya Tsunoda; Reiko Okubo; Kunihiro Yamagata
Journal:  PLoS One       Date:  2019-05-17       Impact factor: 3.240

6.  Dental restorative treatment expenditure and resource utilization in patients with chronic kidney disease: A nationwide population-based study.

Authors:  Ren-Yeong Huang; Yuh-Feng Lin; Sen-Yeong Kao; Yi-Shing Shieh; Jin-Shuen Chen
Journal:  J Dent Sci       Date:  2017-04-23       Impact factor: 2.080

7.  Burden and management of chronic kidney disease in Japan: systematic review of the literature.

Authors:  Karin Travers; Amber Martin; Zarmina Khankhel; Kristina S Boye; Lauren J Lee
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-01-03

8.  A retrospective case-control analysis of the outpatient expenditures for western medicine and dental treatment modalities in CKD patients in Taiwan.

Authors:  Ren-Yeong Huang; Yuh-Feng Lin; Sen-Yeong Kao; Yi-Shing Shieh; Jin-Shuen Chen
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

9.  Disease severity and economic burden in Japanese patients with systemic lupus erythematosus: A retrospective, observational study.

Authors:  Yoshiya Tanaka; Akiko Mizukami; Akihiro Kobayashi; Chie Ito; Taizo Matsuki
Journal:  Int J Rheum Dis       Date:  2018-08       Impact factor: 2.454

10.  Nudging patients with chronic kidney disease at screening to visit physicians: A protocol of a pragmatic randomized controlled trial.

Authors:  Shingo Fukuma; Tatsuyoshi Ikenoue; Shusaku Sasaki; Yusuke Saigusa; Toshihiro Misumi; Yoshiyuki Saito; Yukari Yamada; Rei Goto; Masataka Taguri
Journal:  Contemp Clin Trials Commun       Date:  2019-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.